Clinical Trials Browser

Phase 2 × Interventional × Antimony Sodium Gluconate × Clear all

NCT04906031 2021-06-09

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute